Skip to main content
. 2021 Sep 13;4(9):e2125055. doi: 10.1001/jamanetworkopen.2021.25055

Table 1. Univariate and Multivariate Cox Proportional Hazards Regression Analyses of Prognostic Factors for RFS in the Training Cohort.

Variable Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) β estimate P value
Age (>50 vs ≤50 y) 0.751 (0.502-1.124) .16 NA NA NA
Sex (male vs female) 1.747 (0.879-3.470) .11 NA NA NA
HBV infection (positive vs negative) 1.261 (0.655-2.428) .49 NA NA NA
HCV infection (positive vs negative) 2.141 (0.298-15.380) .45 NA NA NA
Platelet count (>100 × 103/μL vs ≤100 × 103/μL) 1.200 (0.623-2.310) .59 NA NA NA
Albumin level (>3.5 vs ≤3.5 g/dL) 2.276 (0.924-5.606) .07 NA NA NA
Total bilirubin level (>1.0 vs ≤1.0 mg/dL) 0.966 (0.590-1.581) .89 NA NA NA
AFP level in ng/mL (ln) 1.071 (1.007-1.139) .03 NA NA NA
Prothrombin time (>13.5 vs ≤13.5 s) 1.190 (0.484-2.929) .71 NA NA NA
Neutrophil count (>6300/μL vs ≤6300/μL) 1.442 (0.769-2.705) .25 NA NA NA
WBC count (>10 × 103/μL vs ≤10 × 103/μL) 0.965 (0.392-2.376) .94 NA NA NA
CRP level (>0.3 vs ≤0.3 mg/dL) 1.661 (1.108-2.491) .01 NA NA NA
ALT level (>40 vs ≤40 U/L) 1.289 (0.864-1.925) .21 NA NA NA
AST level (>35 vs ≤35 U/L) 1.420 (0.949-2.127) .09 NA NA NA
Liver cirrhosis (present vs absent) 1.200 (0.794-1.814) .39 NA NA NA
Child-Pugh grade (B vs A) 1.614 (0.225-11.602) .63 NA NA NA
VETC (positive vs negative) 2.349 (1.554-3.553) <.001 1.853 (1.203-2.855) 0.617 .005
MVI (positive vs negative) 2.628 (1.756-3.933) <.001 1.780 (1.146-2.766) 0.577 .01
No. of tumors (multiple vs single) 2.666 (1.626-4.371) <.001 2.537 (1.533-4.200) 0.931 <.001
Maximum tumor size in cm (ln) 2.266 (1.561-3.290) <.001 1.714 (1.170-2.511) 0.539 .006
Tumor differentiation (poor/moderate vs well) 2.615 (1.063-6.436) .04 NA NA NA
Anatomical resection (yes vs no) 1.606 (1.050-2.458) .03 NA NA NA
Surgical margin (>1 vs ≤1 cm) 0.822 (0.539-1.252) .36 NA NA NA

Abbreviations: AFP, α-fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; HBV, hepatitis B virus; HCV, hepatitis C virus; HR, hazard ratio; ln, log normal; MVI, microvascular invasion; NA, not applicable; RFS, recurrence-free survival; VETC, vessels encapsulating tumor clusters; WBC, white blood cell.

SI conversion factors: To convert albumin to g/L, multiply by 10; ALT and AST to μkat/L, multiply by 0.0167; bilirubin to μmol/L, multiply by 17.104; CRP to mg/L, multiply by 10; neutrophil count and WBC to ×109/L, multiply by 0.001; platelets to ×109/L, multiply by 1.0.